We support drug substance process development at every stage, from early discovery through commercialization. Our teams work as an extension of yours, bringing deep technical insight to the design, execution, analysis, and documentation of development programs. This includes comprehensive process risk assessments, QbD studies, and the development of mechanistic and statistical models that enable informed decisions and build a strong foundation for scale‑up and regulatory success. We also deliver high‑quality source documentation to support process‑specific sections of INDs, IND amendments, and NDAs.

We provide leadership in emerging regulatory challenges. We have pioneered innovative, practical control strategies for nitrosamine risk assessment and mitigation, helping teams deliver scientifically robust, regulator‑ready filings while protecting process efficiency and development timelines.

Contact us to learn how we can help advance your program with confidence—from first experiments to commercial launch.